Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference
Matt Biegler summarizes a breast cancer panel from the conference and talks about recent data from Relay and upcoming data from Gilead. Plus, he comments on recent uveal melanoma data from IDEAYA Biosciences.
Brought to you by: